NanoVibronix, Inc. (NASDAQ:NAOV) Short Interest Update

NanoVibronix, Inc. (NASDAQ:NAOV) was the recipient of a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 175,700 shares, a decline of 65.9% from the October 15th total of 515,200 shares. Based on an average daily volume of 167,200 shares, the days-to-cover ratio is currently 1.1 days. Approximately 4.7% of the company’s shares are sold short.

NanoVibronix Trading Up 6.0 %

Shares of NASDAQ NAOV traded up $0.04 during trading hours on Tuesday, hitting $0.71. 62,051 shares of the company traded hands, compared to its average volume of 96,678. NanoVibronix has a 12 month low of $0.46 and a 12 month high of $1.55. The stock has a market capitalization of $1.97 million, a price-to-earnings ratio of -0.57 and a beta of 1.51. The company’s 50 day moving average price is $0.60 and its 200 day moving average price is $0.68.

NanoVibronix (NASDAQ:NAOV) last released its earnings results on Wednesday, August 14th. The company reported ($0.25) earnings per share (EPS) for the quarter. NanoVibronix had a negative return on equity of 74.98% and a negative net margin of 83.49%. The firm had revenue of $0.82 million during the quarter.

NanoVibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.